Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

ANDY mouse mimics age-dependent NAD decline and its metabolic impact

March 31, 2022

LG Chem discovers diacylglycerol O-acyltransferase 2 inhibitors

March 29, 2022

PPARgamma isoforms have specific and separable roles in gene regulation and metabolism

March 25, 2022

Gasherbrum Bio identifies GLP-1 receptor agonists

March 25, 2022

Nonhormonal male contraceptive prevents pregnancy in partners

March 24, 2022

NeonMind's preclinical data show efficacy of psilocybin in reducing weight gain in obese animals

March 24, 2022

Abbisko Therapeutics synthesizes new FGFR2/FGFR3 inhibitors

March 23, 2022

Gasherbrum Bio discloses GLP-1 receptor agonists

March 23, 2022

Sosei Heptares presents preclinical data on SST5 receptor agonist HTL-0030310

March 23, 2022

iTolerance raises financing to advance preclinical programs based on iTOL-100 platform technology

March 22, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...